Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Albert Khavkin

Pain Medicine Las Vegas, NV Doctor of Osteopathy

NPI 1871534578 CMS profile 872003

204 Luxaire Ct, Las Vegas, NV 89144

Open in the dashboard

General payments

$3,066

85 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Albert Khavkin of Las Vegas, NV is reported in the CMS Open Payments database as having received $3,066 across 85 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 56th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $87 3
2024 General $363 4
2023 General $135 6
2022 General $377 7
2021 General $774 26
2020 General $632 18
2019 General $698 21

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Albert Khavkin
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Albert Khavkin were reported at $87. Among 2,779 Pain Medicine profiles paid that year, the median was $458 and the middle half received between $124 and $1,401.

Show as a table
Year Albert Khavkin Pain Medicine median Middle half National median
2019 $698 $498 $126–$1,682 $163
2020 $632 $284 $80–$910 $114
2021 $774 $399 $112–$1,219 $132
2022 $377 $455 $137–$1,484 $149
2023 $135 $484 $128–$1,495 $160
2024 $363 $498 $131–$1,540 $164
2025 $87 $458 $124–$1,401 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $2,289 68 payments
  2. Boston Scientific Corporation $344 3 payments
  3. Abbott Laboratories $285 7 payments
  4. BIOTRONIK NRO, Inc. $68 2 payments
  5. Medtronic USA, Inc. $23 2 payments
  6. Bioventus LLC $19 1 payment
  7. Teva Pharmaceuticals USA, Inc. $19 1 payment
  8. Biocomposites Inc $19 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,066 85 payments
Products named General payments · program years 2019–2025
  1. VITOSS $661 21 payments
  2. CASCADIA INTERBODY SYSTEM Spine $216 5 payments
  3. EVEREST SPINAL SYSTEM $178 5 payments
  4. CASCADIA INTERBODY SYSTEM Spine $170 5 payments
  5. CoverEdge 32 $161 1 payment
  6. DENALI $160 4 payments
  7. PROCLAIM $151 1 payment
  8. PENTA $135 6 payments
  9. VLIFT $101 2 payments
  10. YUKON $72 1 payment
  11. Other $832 30 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 24 billing codes

Paid by Medicare

$18,149

Medicare's payments for the services billed

Medicare patients

140

Average age 71

Services billed

172

85 women, 55 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 37%
Depression 34%
Ischemic heart disease 31%
Chronic kidney disease 28%
Heart failure 19%
COPD 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

85 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Nevada

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record